This is a Validated Antibody Database (VAD) review about dog CLDN1, based on 98 published articles (read how Labome selects the articles), using CLDN1 antibody in all methods. It is aimed to help Labome visitors find the most suited CLDN1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CLDN1 synonym: claudin-1

Invitrogen
rabbit polyclonal (MH25)
  • immunocytochemistry; mouse; loading ...; fig 3a
Invitrogen CLDN1 antibody (Thermo Fisher, 717800) was used in immunocytochemistry on mouse samples (fig 3a). Biochim Biophys Acta Mol Basis Dis (2018) ncbi
rabbit polyclonal (MH25)
  • western blot; rat; 1:250; fig 7c
In order to describe the colonic epithelial response to a high-protein diet, Invitrogen CLDN1 antibody (Invitrogen, 717800) was used in western blot on rat samples at 1:250 (fig 7c). BMC Genomics (2017) ncbi
rabbit polyclonal (MH25)
  • western blot; human; loading ...; fig 6c
In order to test if HAI-2, matriptase, EpCAM, and claudin-7 are functionally linked in the intestine, Invitrogen CLDN1 antibody (Life Technologies, 71-7800) was used in western blot on human samples (fig 6c). J Clin Invest (2017) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:2000; loading ...; fig 4d
In order to investigate whether hepatitis C virus has a genetically determined lymphotropism through a co-receptor specific for the infection by lymphotropic hepatitis C virus, Invitrogen CLDN1 antibody (ZYMED, 37-4900) was used in western blot on human samples at 1:2000 (fig 4d). Nat Commun (2017) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; 1:100; loading ...
  • western blot; human; 1:1000; loading ...; tbl 3
In order to report the presence of PIWI-like proteins in somatic cells and the possible role of HIWI2 in preserving the functional integrity of epithelial cells, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples at 1:1000 (tbl 3). Mol Cell Biochem (2017) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; human; 1:50; loading ...; fig 1b
In order to ask if podocyturia increases in Fabry patients and correlates with clinical severity of Fabry nephropathy, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in immunocytochemistry on human samples at 1:50 (fig 1b). PLoS ONE (2016) ncbi
mouse monoclonal (2H10D10)
  • flow cytometry; human; 1:100; loading ...; fig 3a
  • immunoprecipitation; human; loading ...; fig 6
  • immunocytochemistry; human; 1:100; loading ...; fig 3c
  • western blot; human; 1:500; loading ...; fig 11a
In order to ascertain how claudin-6 is associated with MMP-2 activation and cell invasiveness, Invitrogen CLDN1 antibody (Invitrogen, 374900) was used in flow cytometry on human samples at 1:100 (fig 3a), in immunoprecipitation on human samples (fig 6), in immunocytochemistry on human samples at 1:100 (fig 3c) and in western blot on human samples at 1:500 (fig 11a). Exp Cell Res (2017) ncbi
rabbit polyclonal (MH25)
  • immunohistochemistry; mouse; loading ...; fig 3e
In order to suggest that planar cell polarity signaling governs directed epithelial evaginations to form crypts for implantation in mice, Invitrogen CLDN1 antibody (Thermo Scientific, 71-7800) was used in immunohistochemistry on mouse samples (fig 3e). Proc Natl Acad Sci U S A (2016) ncbi
rabbit polyclonal (MH25)
  • western blot; human; 1:1000; loading ...; fig 2a
In order to examine the role of Salmonella AvrA during infection, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on human samples at 1:1000 (fig 2a). J Biol Chem (2016) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; rabbit; 1:100; loading ...; fig 6a
  • western blot; rabbit; 1:1000; loading ...; fig 6b
In order to investigate the role of TRPV4 in a corneal epithelial cell model, Invitrogen CLDN1 antibody (Thermo Fisher, 71-7800) was used in immunocytochemistry on rabbit samples at 1:100 (fig 6a) and in western blot on rabbit samples at 1:1000 (fig 6b). J Cell Physiol (2017) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:50; loading ...; fig 5e
In order to test if long-term exposure to short chain fatty acids affects the transport and metabolism of (poly)phenols by the intestinal epithelium, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on human samples at 1:50 (fig 5e). J Nutr Biochem (2017) ncbi
rabbit polyclonal (MH25)
  • western blot; rat; 1:1000; loading ...; fig 5a
In order to assess the contribution of mutated prostasin in dextran sodium sulfate-induced colitis, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on rat samples at 1:1000 (fig 5a). Inflamm Bowel Dis (2016) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; dog; loading ...; fig 7a
  • western blot; dog; loading ...; fig 1b
  • western blot; human; fig 1a
In order to elucidate the mechanism by which hypotonic stress reduces claudin-1 and -2 expression in renal tubular epithelial and canine kidney cells, Invitrogen CLDN1 antibody (Zymed Laboratories, 71-7800) was used in immunocytochemistry on dog samples (fig 7a), in western blot on dog samples (fig 1b) and in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:200; loading ...; fig 3f
In order to test if D1-like receptors regulate duodenal permeability, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on human samples at 1:200 (fig 3f). Acta Physiol (Oxf) (2017) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; dog; 1:200; loading ...; fig 2a
  • western blot; dog; 1:1000; loading ...; fig 1e
In order to measure tight junction protein expression in canine duodenum, lung, liver, and kidney, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunohistochemistry - paraffin section on dog samples at 1:200 (fig 2a) and in western blot on dog samples at 1:1000 (fig 1e). Mol Med Rep (2016) ncbi
rabbit polyclonal (MH25)
  • western blot; mouse; 1:250; loading ...; fig 7a
In order to assess the effects of dietary protein using a model of colitis, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on mouse samples at 1:250 (fig 7a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; 1:100; loading ...; fig 4
In order to investigate puerarin transport in a nasal mucosa model, Invitrogen CLDN1 antibody (Thermo Fisher, 2H10D10) was used in immunocytochemistry on human samples at 1:100 (fig 4). Drug Des Devel Ther (2016) ncbi
mouse monoclonal (2H10D10)
  • western blot; mouse; 1:1000; fig 3
In order to study prevention of allergic skin disease by epidermal RAF, Invitrogen CLDN1 antibody (Invitrogen, 374900) was used in western blot on mouse samples at 1:1000 (fig 3). elife (2016) ncbi
rabbit polyclonal (MH25)
  • immunohistochemistry; mouse; loading ...; fig 3c
In order to use transgenic mice to clarify the role of LKB1 in the maintenance of functional tight junction, Invitrogen CLDN1 antibody (Thermo Fisher, 71-7800) was used in immunohistochemistry on mouse samples (fig 3c). Hepatology (2016) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; mouse; fig 2
In order to assess the induction of colonic epithelial cell stress and inflammation reversed by IL-22 due to high fat diets, Invitrogen CLDN1 antibody (Novex, 374900) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to analyze the rescue of intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation due to ERK5 signaling, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Nat Commun (2016) ncbi
rabbit polyclonal (MH25)
  • western blot; human; fig 2
In order to elucidate regulation of E-cadherin and CD24 by determination of cell fate transition and impeding tumor initiation and progression in breast cancer via HOXA5, Invitrogen CLDN1 antibody (Thermo Fisher Scientific, 71-7800) was used in western blot on human samples (fig 2). Oncogene (2016) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; equine; fig 2
  • western blot; equine; 1:1000; fig 1
In order to compare expression levels and distribution of Claudin-1, 2, 4, and 5 in equine tissues, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunohistochemistry - paraffin section on equine samples (fig 2) and in western blot on equine samples at 1:1000 (fig 1). J Vet Sci (2016) ncbi
mouse monoclonal (2H10D10)
  • western blot; mouse; fig 4
In order to study the reduction of inflammatory mediators, symptoms, and mast cell markers in murine IL-10 (-/-) colitis due to cinnamon extract, Invitrogen CLDN1 antibody (Life Technologies, 2H10D10) was used in western blot on mouse samples (fig 4). J Nutr Biochem (2016) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; mouse; fig 3
In order to study a reconstituted choroid plexus epithelium to show T-lymphocytes traffic into the brain across the blood-CSF barrier, Invitrogen CLDN1 antibody (Life Technologies, 71-7800) was used in immunocytochemistry on mouse samples (fig 3). PLoS ONE (2016) ncbi
rabbit polyclonal (MH25)
  • western blot; mouse; 1:1000; fig s2
In order to study anorectic mice for improved body composition and intestinal hypermeability and behavior due to maintaining of physical activity during refeeding, Invitrogen CLDN1 antibody (LifeTechnologies, 717800) was used in western blot on mouse samples at 1:1000 (fig s2). Sci Rep (2016) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:50; fig 3
In order to characterize upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4) byan increase in transepithelial transport of ferulic acid by butyric acid, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on human samples at 1:50 (fig 3). Arch Biochem Biophys (2016) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 2
In order to characterize barrier breakdown and MAPK/NF-kappaB mediated stress response in the intestinal epithelial cell line C2BBe1 due to Candida albicans infection, Invitrogen CLDN1 antibody (Life Technologies, 2H10D10) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 2). Cell Microbiol (2016) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; fig 1
In order to assess the capacity of primary synovial fibroblasts to support hepatitis C virus propagation, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in western blot on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; mouse; 1:5000
In order to study how Cldn-1 and Cldn-4 are altered in atopic dermatitis, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunohistochemistry - paraffin section on mouse samples at 1:5000. Am J Pathol (2015) ncbi
mouse monoclonal (2H10D10)
  • western blot; human
In order to identify Ca(2+)/calmodulin-dependent protein kinase II as a regulator of the barrier function of tight junctions, Invitrogen CLDN1 antibody (Life Technologies, clone 2H10D10) was used in western blot on human samples . Sci Rep (2015) ncbi
rabbit polyclonal (MH25)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:250; fig 2
In order to study follicular thyroid carcinoma aggressiveness caused by the impact of CLAUDIN-1, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1), in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:250 (fig 2). Endocr Relat Cancer (2015) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; human
  • western blot; human
In order to show that mitochondrial respiratory defects contribute to hepatoma invasiveness, Invitrogen CLDN1 antibody (Invitrogen, 717800) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (2H10D10)
  • western blot; human
In order to examine genetic interactions between claudin-1 and hepatitis C virus, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in western blot on human samples . Hepatology (2015) ncbi
mouse monoclonal (2H10D10)
  • western blot; African green monkey; fig s1b
  • western blot; Rhesus monkey; fig s1b
  • western blot; human; 1:400; fig s1b
In order to identify cellular determinants of interspecies hepatitis C virus transmission and establish an immunocompetent model system, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in western blot on African green monkey samples (fig s1b), in western blot on Rhesus monkey samples (fig s1b) and in western blot on human samples at 1:400 (fig s1b). Hepatology (2015) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; mouse; 1:1000
In order to show that choroid plexus epithelial cells expand in response to injury and growth factors, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in immunocytochemistry on mouse samples at 1:1000. PLoS ONE (2015) ncbi
rabbit polyclonal (MH25)
  • western blot; human; 1:2000
In order to study the effect of cotransin treatment on protein synthesis, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on human samples at 1:2000. PLoS ONE (2015) ncbi
mouse monoclonal (2H10D10)
  • western blot; human
In order to investigate the specific roles of the 3 C-terminal claudin residues by assessing their interactions with PDZ1 of ZO2., Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on human samples . Biochem Biophys Res Commun (2015) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:1000; fig 3
In order to demonstrate that emodin attenuates LPS- and hypoxia/reoxygenation-induced intestinal epithelial barrier dysfunction by inhibiting the HIF-1alpha and NF-kappaB signaling pathways, which regulate tight junctions, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on human samples at 1:1000 (fig 3). Int J Mol Med (2014) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; human
In order to study using RPMI 2650 cells to create an in vitro model of the nasal mucosa, Invitrogen CLDN1 antibody (Zymed-Life Technologies, 71-7800) was used in immunocytochemistry on human samples . Pharm Res (2015) ncbi
rabbit polyclonal (MH25)
  • western blot; human; 1:500
In order to evaluate claudin 2 as a proximal tubular stress responsive paracellular water channel, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used in western blot on human samples at 1:500. Toxicol Appl Pharmacol (2014) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2
In order to compare tricellulin expression in normal and cirrhotic liver with that of primary hepatic neoplasms, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2). Pathol Oncol Res (2014) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; 5 ug/ml; loading ...; fig s5
In order to identify a cell line that supports the entire life cycle of hepatitis B and hepatitis C viruses, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunocytochemistry on human samples at 5 ug/ml (fig s5). Proc Natl Acad Sci U S A (2014) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; mouse; 1:50
In order to study the effect of activity-based anorexia on intestinal barrier function in mice, Invitrogen CLDN1 antibody (Zymed Laboratories, 71-7800) was used in immunocytochemistry on mouse samples at 1:50. Clin Nutr (2014) ncbi
mouse monoclonal (2H10D10)
  • western blot; mouse; 1:1000
In order to study the effect of activity-based anorexia on intestinal barrier function in mice, Invitrogen CLDN1 antibody (Zymed Laboratories, 37-4900) was used in western blot on mouse samples at 1:1000. Clin Nutr (2014) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; dog; fig 3
In order to study the molecular mechanisms underlying the reversible effects of capsaicin on tight junction permeability, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in immunocytochemistry on dog samples (fig 3). PLoS ONE (2013) ncbi
rabbit polyclonal (MH25)
  • immunohistochemistry; mouse; 1:250; fig 3
In order to study the effects of the BPP-10c and captopril on the structure and function of the seminiferous epithelium, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used in immunohistochemistry on mouse samples at 1:250 (fig 3). J Venom Anim Toxins Incl Trop Dis (2013) ncbi
rabbit polyclonal (MH25)
  • western blot; mouse; 1:200; fig 3
In order to investigate the effects of antioxidants on Nf1 loss or HRas hyper activation in mouse oligodendrocytes, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on mouse samples at 1:200 (fig 3). Cell Rep (2013) ncbi
rabbit polyclonal (MH25)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 2
In order to investigate the expression of the tight junction proteins occludin, claudin-1 and ZO-2 in the epidermis of female mice, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2). Exp Cell Res (2013) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - frozen section; mouse; fig 7
In order to investigate the roles of IFN-alpha and IFN-beta in viral glomerulonephritis, Invitrogen CLDN1 antibody (Invitrogen, clone 2H10D10) was used in immunohistochemistry - frozen section on mouse samples (fig 7). Am J Pathol (2013) ncbi
mouse monoclonal (2H10D10)
  • western blot; mouse; 3 ug/ml; fig 3
In order to develop surgical models of duodenal and mixed reflux using mice, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on mouse samples at 3 ug/ml (fig 3). Am J Physiol Gastrointest Liver Physiol (2013) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:2000; fig 5
In order to examine the contribution of various tight junction proteins in keratinocytes, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:2000 (fig 5). J Invest Dermatol (2013) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; 1:150; tbl 1
In order to observe changes in tight junction proteins in various epithelial tumors, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in immunocytochemistry on human samples at 1:150 (tbl 1). PLoS ONE (2013) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; fig 1, 2
In order to study the roles of MAPK-related kinase and MKNK-1 in HCV replication and cellular entry, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in western blot on human samples (fig 1, 2). J Virol (2013) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; mouse; fig 4
In order to determine the role of Cbx4 in thymic organogenesis, Invitrogen CLDN1 antibody (Zymed, 37-4900) was used in immunocytochemistry on mouse samples (fig 4). Development (2013) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; fig 2
In order to investigate the assembly and disassembly of tricellular in tight junctions by altering the calcium concentration, Invitrogen CLDN1 antibody (Zymed Laboratories, 2H10D10) was used in immunocytochemistry on human samples (fig 2). Cell Tissue Res (2013) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; fig 4
In order to use a novel cell-based model system to study phenotypic plasticity in triple-negative breast cancer, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in western blot on human samples (fig 4). PLoS ONE (2012) ncbi
rabbit polyclonal (MH25)
  • western blot; human; fig 2
In order to test if GLP-2 regulates tight junctions, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on human samples (fig 2). Regul Pept (2012) ncbi
mouse monoclonal (2H10D10)
  • western blot; mouse; fig 7
In order to study the function of dysferlin and myoferlin in airway epithelial homeostasis, Invitrogen CLDN1 antibody (Life Technologies, 37-4900) was used in western blot on mouse samples (fig 7). PLoS ONE (2012) ncbi
mouse monoclonal (2H10D10)
  • flow cytometry; human; fig 5
In order to examine the entry of infectious virus subpopulations with different buoyant densities, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in flow cytometry on human samples (fig 5). J Biol Chem (2012) ncbi
rabbit polyclonal (MH25)
  • immunocytochemistry; human; 1:300; fig 4
  • western blot; human; 1:500; fig 6
In order to determine the effects of KBrO(3) using human and rat proximal tubular cell lines, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used in immunocytochemistry on human samples at 1:300 (fig 4) and in western blot on human samples at 1:500 (fig 6). Arch Toxicol (2012) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 2
In order to develop and characterize a model for Hailey-Hailey disease using normal keratinocytes, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 2). Exp Dermatol (2012) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; rat; 1:50; fig 4a
In order to assess the effects of opioids on tight junction proteins, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 4a). Anesthesiology (2012) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; rabbit; 1:500; fig 4
In order to characterize infant rabbits infected with Vibrio parahaemolyticus, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunohistochemistry - paraffin section on rabbit samples at 1:500 (fig 4). PLoS Pathog (2012) ncbi
mouse monoclonal (2H10D10)
  • flow cytometry; mouse; fig 3
  • western blot; mouse; fig s1
In order to identify Cldn1, Cldn2 and Cldn11 as genes that discriminate between diverse types of M2, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in flow cytometry on mouse samples (fig 3) and in western blot on mouse samples (fig s1). Scand J Immunol (2012) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; fig 1
In order to examine the functions of symplekin at tight junctions, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunocytochemistry on human samples (fig 1). Histochem Cell Biol (2012) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; fig 1
In order to assess the changes in claudins function via PKCalpha activation in pancreatic cancer cells, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in western blot on human samples (fig 1). Cell Tissue Res (2011) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; rat; 1:3000; fig 2
In order to study the effects of lipopolysaccharide on the expression of tight junction-associated molecule genes in the junctional epithelium, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunohistochemistry - paraffin section on rat samples at 1:3000 (fig 2). J Periodontal Res (2012) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry; chicken; 1:200; fig 3
In order to demonstrate that cingulin is critical for neural crest migration, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunohistochemistry on chicken samples at 1:200 (fig 3). Dev Dyn (2011) ncbi
rabbit polyclonal (MH25)
  • western blot; human; 1:200; fig 2
In order to examine the function and location of tight junction proteins in immune cells, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used in western blot on human samples at 1:200 (fig 2). J Cell Mol Med (2012) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; fig 2
In order to investigate how the differences between human and murine occludin contribute to hepatitis C virus spread, Invitrogen CLDN1 antibody (Zymed/Invitrogen, clone 2H10D10) was used in western blot on human samples (fig 2). J Virol (2011) ncbi
rabbit polyclonal (MH25)
  • immunohistochemistry; mouse
  • western blot; mouse; fig s2
In order to study the role of CD44 in tight-junction assembly and barrier function, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used in immunohistochemistry on mouse samples and in western blot on mouse samples (fig s2). J Invest Dermatol (2011) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3a
In order to investigate the role of Merlin in adheren junction establishment, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in immunohistochemistry on mouse samples at 1:100 (fig 3a). Dev Cell (2010) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3c
In order to investigate suppression of dendritic cell function during HIV-1 infection, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in immunohistochemistry on mouse samples at 1:100 (fig 3c). J Immunol (2010) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; 1:80; fig 9
  • western blot; human; fig 8
In order to investigate occludin-mediated hepatitis C virus entry, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in immunocytochemistry on human samples at 1:80 (fig 9) and in western blot on human samples (fig 8). Virology (2010) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry; human; fig 5
In order to report how modulation of Notch activation in human renal progenitors affects different cellular processes, Invitrogen CLDN1 antibody (Invitrogen, 2H10D10) was used in immunohistochemistry on human samples (fig 5). Stem Cells (2010) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; fig 1
In order to test if cells originating from the brain or central nervous system are permissive for HCV cell entry, RNA replication, and virus assembly, Invitrogen CLDN1 antibody (Zymed, clone 2H10010) was used in western blot on human samples (fig 1). J Viral Hepat (2011) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:1000; fig 4
In order to test if the c-Jun N-terminal kinase pathway regulates tricellulin, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in western blot on human samples at 1:1000 (fig 4). J Cell Physiol (2010) ncbi
mouse monoclonal (2H10D10)
In order to discuss the impact of corticosteroid treatment on hepatitis C virus recurrence after liver transplantation, Invitrogen CLDN1 antibody (Zymed, 2H10010) was used . Gastroenterology (2010) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry; cat; 1:50; fig 1c
  • immunohistochemistry; human; 1:50; fig 1a
In order to investigate if the expression pattern of tight junction proteins in mice, rabbits, and cats resemble those of humans, Invitrogen CLDN1 antibody (Invitrogen, 37-4900) was used in immunohistochemistry on cat samples at 1:50 (fig 1c) and in immunohistochemistry on human samples at 1:50 (fig 1a). Biotech Histochem (2011) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry; human; 1:100; fig 2
In order to determine the expression and localization of tricellulin, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in immunohistochemistry on human samples at 1:100 (fig 2). Med Mol Morphol (2009) ncbi
mouse monoclonal (2H10D10)
  • western blot; human; 1:500; fig 3
In order to report that infectious hepatitis C virus mimics very low density lipoprotein which contributes to cell entry, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in western blot on human samples at 1:500 (fig 3). Virology (2009) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; 1:100; loading ...; fig 4
  • western blot; human; loading ...; fig 3c
In order to test if patulin alters the barrier function of intestinal cells, Invitrogen CLDN1 antibody (Zymed, 2H10d10) was used in immunocytochemistry on human samples at 1:100 (fig 4) and in western blot on human samples (fig 3c). Toxicol In Vitro (2009) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; fig 6c
  • western blot; human; fig 6b
In order to investigate the function of fatty acid synthase in cells infected with hepatitis C virus, Invitrogen CLDN1 antibody (Zymed/Invitrogen, 2H10D10) was used in immunocytochemistry on human samples (fig 6c) and in western blot on human samples (fig 6b). Hepatology (2008) ncbi
mouse monoclonal (2H10D10)
  • immunocytochemistry; human; fig 3c
In order to study tight junction proteins in ECV304 cells, Invitrogen CLDN1 antibody (Zymed, 37-4900) was used in immunocytochemistry on human samples (fig 3c). Neurosci Lett (2008) ncbi
mouse monoclonal (2H10D10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
In order to study translocation of HIV across the vaginal pluristratified epithelium, Invitrogen CLDN1 antibody (Zymed, 2H10D10) was used in immunohistochemistry - paraffin section on human samples (fig 2a). AIDS (2008) ncbi
mouse monoclonal (2H10D10)
  • western blot; human
In order to find Claudin-1 co-immunoprecipitates with HCV envelope proteins in 293T cells, Invitrogen CLDN1 antibody (Zymed Laboratories, 2H10D10) was used in western blot on human samples . J Biol Chem (2008) ncbi
rabbit polyclonal (MH25)
In order to analyze the localizations of Cldn1, Cldn6, Cldn11, and Cldn18, and the presence of Cldn3 and Cldn5 in various neonatal mouse epithelia, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . Cell Tissue Res (2007) ncbi
rabbit polyclonal (MH25)
In order to report that capsid contributes to astrovirus infection-induced diarrhea, Invitrogen CLDN1 antibody (Invitrogen, 71-7800) was used . J Virol (2007) ncbi
rabbit polyclonal (MH25)
In order to explore whether claudin expression modulations reflect an injury response in the murine epidermis, Invitrogen CLDN1 antibody (Zymed, 71?C7800) was used . J Invest Dermatol (2008) ncbi
rabbit polyclonal (MH25)
In order to examine the expression and function of tight junctions in the epithelium of human palatine tonsils from patients with tonsillar hypertrophy or recurrent tonsillitis, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . J Histochem Cytochem (2004) ncbi
rabbit polyclonal (MH25)
In order to identify tight junctions involved in the formation of the embryonic diffusion barrier, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . Exp Cell Res (2004) ncbi
rabbit polyclonal (MH25)
In order to examine the roles of gap junctional intercellular communication in the regulation of the barrier function of tight junctions, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . Exp Cell Res (2004) ncbi
rabbit polyclonal (MH25)
In order to investigate the effects of Src tyrosine kinase activation in temperature sensitive-Src-transformed Madin-Darby canine kidney cells, Invitrogen CLDN1 antibody (Zymed, 71?C7800) was used . Lab Invest (2003) ncbi
rabbit polyclonal (MH25)
In order to assess the effect of interferon-gamma on the barrier function of primary cultured human thyrocytes, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . Eur J Endocrinol (2003) ncbi
rabbit polyclonal (MH25)
In order to investigate the role of myosin in vectorial transport, Invitrogen CLDN1 antibody (Zymed, 717800) was used . J Muscle Res Cell Motil (2002) ncbi
rabbit polyclonal (MH25)
In order to assess the effect of adding an extract of dog urine to monolayers of MDCK cells, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . J Membr Biol (2002) ncbi
rabbit polyclonal (MH25)
In order to investigate tight junctions and E-cadherin in heterotypic borders, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . Pflugers Arch (2002) ncbi
rabbit polyclonal (MH25)
In order to examine the differential expression of occludin and several claudins in isolated renal tubules from newborn and adult rabbits, Invitrogen CLDN1 antibody (Zymed, 71-7800) was used . Kidney Int (2002) ncbi
Articles Reviewed
  1. Rogerson C, Gissen P. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1609-1621 pubmed publisher
  2. Beaumont M, Andriamihaja M, Armand L, Grauso M, Jaffrézic F, Laloë D, et al. Epithelial response to a high-protein diet in rat colon. BMC Genomics. 2017;18:116 pubmed publisher
  3. Wu C, Feng X, Lu M, Morimura S, Udey M. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis. J Clin Invest. 2017;127:623-634 pubmed publisher
  4. Chen C, Huang J, Wang C, Tahara S, Zhou L, Kondo Y, et al. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2. Nat Commun. 2017;8:13882 pubmed publisher
  5. Sivagurunathan S, Palanisamy K, Arunachalam J, Chidambaram S. Possible role of HIWI2 in modulating tight junction proteins in retinal pigment epithelial cells through Akt signaling pathway. Mol Cell Biochem. 2017;427:145-156 pubmed publisher
  6. Fall B, Scott C, Mauer M, Shankland S, Pippin J, Jefferson J, et al. Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy. PLoS ONE. 2016;11:e0168346 pubmed publisher
  7. Torres Martínez A, Gallardo Vera J, Lara Holguin A, Montano L, Rendón Huerta E. Claudin-6 enhances cell invasiveness through claudin-1 in AGS human adenocarcinoma gastric cancer cells. Exp Cell Res. 2017;350:226-235 pubmed publisher
  8. Yuan J, Cha J, Deng W, Bartos A, Sun X, Ho H, et al. Planar cell polarity signaling in the uterus directs appropriate positioning of the crypt for embryo implantation. Proc Natl Acad Sci U S A. 2016;113:E8079-E8088 pubmed
  9. Lin Z, Zhang Y, Xia Y, Xu X, Jiao X, Sun J. Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway. J Biol Chem. 2016;291:26837-26849 pubmed publisher
  10. Martínez Rendón J, Sánchez Guzmán E, Rueda A, González J, Gulias Cañizo R, Aquino Jarquin G, et al. TRPV4 Regulates Tight Junctions and Affects Differentiation in a Cell Culture Model of the Corneal Epithelium. J Cell Physiol. 2017;232:1794-1807 pubmed publisher
  11. Van Rymenant E, Abranko L, Tumova S, Grootaert C, Van Camp J, Williamson G, et al. Chronic exposure to short-chain fatty acids modulates transport and metabolism of microbiome-derived phenolics in human intestinal cells. J Nutr Biochem. 2017;39:156-168 pubmed publisher
  12. Keppner A, Malsure S, Nobile A, Auberson M, Bonny O, Hummler E. Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis. Inflamm Bowel Dis. 2016;22:2824-2839 pubmed
  13. Fujii N, Matsuo Y, Matsunaga T, Endo S, Sakai H, Yamaguchi M, et al. Hypotonic Stress-induced Down-regulation of Claudin-1 and -2 Mediated by Dephosphorylation and Clathrin-dependent Endocytosis in Renal Tubular Epithelial Cells. J Biol Chem. 2016;291:24787-24799 pubmed
  14. Feng X, Zhang D, Wang Y, Fan R, Hong F, Zhang Y, et al. Dopamine enhances duodenal epithelial permeability via the dopamine D5 receptor in rodent. Acta Physiol (Oxf). 2017;220:113-123 pubmed publisher
  15. Ahn C, Shin D, Lee D, Kang S, Seok J, Kang H, et al. Expression of claudins, occludin, junction adhesion molecule A and zona occludens 1 in canine organs. Mol Med Rep. 2016;14:3697-703 pubmed publisher
  16. Lan A, Blais A, Coelho D, Capron J, Maarouf M, Benamouzig R, et al. Dual effects of a high-protein diet on DSS-treated mice during colitis resolution phase. Am J Physiol Gastrointest Liver Physiol. 2016;311:G624-G633 pubmed publisher
  17. Zhang L, Du S, Lu Y, Liu C, Tian Z, Yang C, et al. Puerarin transport across a Calu-3 cell monolayer - an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol. Drug Des Devel Ther. 2016;10:2227-37 pubmed publisher
  18. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  19. Porat Shliom N, Tietgens A, Van Itallie C, Vitale Cross L, Jarnik M, Harding O, et al. Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo. Hepatology. 2016;64:1317-29 pubmed publisher
  20. Gulhane M, Murray L, Lourie R, Tong H, Sheng Y, Wang R, et al. High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22. Sci Rep. 2016;6:28990 pubmed publisher
  21. de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed publisher
  22. Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R, et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35:5539-5551 pubmed publisher
  23. Lee B, Kang H, Lee D, Ahn C, Jeung E. Claudin-1, -2, -4, and -5: comparison of expression levels and distribution in equine tissues. J Vet Sci. 2016;17:445-451 pubmed publisher
  24. Hagenlocher Y, Hösel A, Bischoff S, Lorentz A. Cinnamon extract reduces symptoms, inflammatory mediators and mast cell markers in murine IL-10(-/-) colitis. J Nutr Biochem. 2016;30:85-92 pubmed publisher
  25. Strazielle N, Creidy R, Malcus C, Boucraut J, Ghersi Egea J. T-Lymphocytes Traffic into the Brain across the Blood-CSF Barrier: Evidence Using a Reconstituted Choroid Plexus Epithelium. PLoS ONE. 2016;11:e0150945 pubmed publisher
  26. Achamrah N, Nobis S, Breton J, Jésus P, Belmonte L, Maurer B, et al. Maintaining physical activity during refeeding improves body composition, intestinal hyperpermeability and behavior in anorectic mice. Sci Rep. 2016;6:21887 pubmed publisher
  27. Ziegler K, Kerimi A, Poquet L, Williamson G. Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4). Arch Biochem Biophys. 2016;599:3-12 pubmed publisher
  28. Böhringer M, Pohlers S, Schulze S, Albrecht Eckardt D, Piegsa J, Weber M, et al. Candida albicans infection leads to barrier breakdown and a MAPK/NF-κB mediated stress response in the intestinal epithelial cell line C2BBe1. Cell Microbiol. 2016;18:889-904 pubmed publisher
  29. Nadeem A, Thomas P, Ulf M, Elena N, Anggakusuma A, Mohamed B, et al. Cell culture-derived HCV cannot infect synovial fibroblasts. Sci Rep. 2015;5:18043 pubmed publisher
  30. Gruber R, Börnchen C, Rose K, Daubmann A, Volksdorf T, Wladykowski E, et al. Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis. Am J Pathol. 2015;185:2777-89 pubmed publisher
  31. Shiomi R, Shigetomi K, Inai T, Sakai M, Ikenouchi J. CaMKII regulates the strength of the epithelial barrier. Sci Rep. 2015;5:13262 pubmed publisher
  32. Zwanziger D, Badziong J, Ting S, Moeller L, Schmid K, Siebolts U, et al. The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness. Endocr Relat Cancer. 2015;22:819-30 pubmed publisher
  33. Lee J, Lee Y, Lim J, Byun H, Park I, Kim G, et al. Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness. J Biol Chem. 2015;290:21421-31 pubmed publisher
  34. Hopcraft S, Evans M. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins. Hepatology. 2015;62:1059-69 pubmed publisher
  35. Scull M, Shi C, De Jong Y, Gerold G, Ries M, von Schaewen M, et al. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology. 2015;62:57-67 pubmed publisher
  36. Barkho B, Monuki E. Proliferation of cultured mouse choroid plexus epithelial cells. PLoS ONE. 2015;10:e0121738 pubmed publisher
  37. Klein W, Westendorf C, Schmidt A, Conill Cortés M, Rutz C, Blohs M, et al. Defining a conformational consensus motif in cotransin-sensitive signal sequences: a proteomic and site-directed mutagenesis study. PLoS ONE. 2015;10:e0120886 pubmed publisher
  38. Wu J, Peng D, Zhang Y, Lu Z, Voehler M, Sanders C, et al. Biophysical characterization of interactions between the C-termini of peripheral nerve claudins and the PDZ₁ domain of zonula occludens. Biochem Biophys Res Commun. 2015;459:87-93 pubmed publisher
  39. Lei Q, Qiang F, Chao D, Di W, Guoqian Z, Bo Y, et al. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways. Int J Mol Med. 2014;34:1629-39 pubmed publisher
  40. Kreft M, Jerman U, Lasič E, Lanišnik Rižner T, Hevir Kene N, Peternel L, et al. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharm Res. 2015;32:665-79 pubmed publisher
  41. Wilmes A, Aschauer L, Limonciel A, Pfaller W, Jennings P. Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol. 2014;279:163-72 pubmed publisher
  42. Somorácz A, Korompay A, Törzsök P, Patonai A, Erdélyi Belle B, Lotz G, et al. Tricellulin expression and its prognostic significance in primary liver carcinomas. Pathol Oncol Res. 2014;20:755-64 pubmed publisher
  43. Yang D, Zuo C, Wang X, Meng X, Xue B, Liu N, et al. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc Natl Acad Sci U S A. 2014;111:E1264-73 pubmed publisher
  44. Jesus P, Ouelaa W, François M, Riachy L, Guérin C, Aziz M, et al. Alteration of intestinal barrier function during activity-based anorexia in mice. Clin Nutr. 2014;33:1046-53 pubmed publisher
  45. Shiobara T, Usui T, Han J, Isoda H, Nagumo Y. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS ONE. 2013;8:e79954 pubmed publisher
  46. Gilio J, Portaro F, Borella M, Lameu C, Camargo A, Alberto Silva C. A bradykinin-potentiating peptide (BPP-10c) from Bothrops jararaca induces changes in seminiferous tubules. J Venom Anim Toxins Incl Trop Dis. 2013;19:28 pubmed publisher
  47. Mayes D, Rizvi T, Titus Mitchell H, Oberst R, Ciraolo G, Vorhees C, et al. Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature. Cell Rep. 2013;4:1197-212 pubmed publisher
  48. Hernández Monge J, Garay E, Raya Sandino A, Vargas Sierra O, Diaz Chavez J, Popoca Cuaya M, et al. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res. 2013;319:2588-603 pubmed publisher
  49. Migliorini A, Angelotti M, Mulay S, Kulkarni O, Demleitner J, Dietrich A, et al. The antiviral cytokines IFN-? and IFN-? modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol. 2013;183:431-40 pubmed publisher
  50. Fang Y, Chen H, Hu Y, Djukic Z, Tevebaugh W, Shaheen N, et al. Gastroesophageal reflux activates the NF-?B pathway and impairs esophageal barrier function in mice. Am J Physiol Gastrointest Liver Physiol. 2013;305:G58-65 pubmed publisher
  51. Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner J. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol. 2013;133:1161-9 pubmed publisher
  52. Rachow S, Zorn Kruppa M, Ohnemus U, Kirschner N, Vidal Y Sy S, von den Driesch P, et al. Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis. PLoS ONE. 2013;8:e55116 pubmed publisher
  53. Kim S, Ishida H, Yamane D, Yi M, Swinney D, Foung S, et al. Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry. J Virol. 2013;87:4214-24 pubmed publisher
  54. Liu B, Liu Y, Du Y, Mardaryev A, Yang W, Chen H, et al. Cbx4 regulates the proliferation of thymic epithelial cells and thymus function. Development. 2013;140:780-8 pubmed publisher
  55. Takasawa A, Kojima T, Ninomiya T, Tsujiwaki M, Murata M, Tanaka S, et al. Behavior of tricellulin during destruction and formation of tight junctions under various extracellular calcium conditions. Cell Tissue Res. 2013;351:73-84 pubmed publisher
  56. D Amato N, OSTRANDER J, Bowie M, Sistrunk C, Borowsky A, Cardiff R, et al. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS ONE. 2012;7:e45684 pubmed publisher
  57. Moran G, O NEILL C, McLaughlin J. GLP-2 enhances barrier formation and attenuates TNF?-induced changes in a Caco-2 cell model of the intestinal barrier. Regul Pept. 2012;178:95-101 pubmed publisher
  58. Leung C, Shaheen F, Bernatchez P, Hackett T. Expression of myoferlin in human airway epithelium and its role in cell adhesion and zonula occludens-1 expression. PLoS ONE. 2012;7:e40478 pubmed publisher
  59. Dao Thi V, Granier C, Zeisel M, Guerin M, Mancip J, Granio O, et al. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J Biol Chem. 2012;287:31242-57 pubmed publisher
  60. Limonciel A, Wilmes A, Aschauer L, Radford R, Bloch K, McMorrow T, et al. Oxidative stress induced by potassium bromate exposure results in altered tight junction protein expression in renal proximal tubule cells. Arch Toxicol. 2012;86:1741-51 pubmed publisher
  61. Raiko L, Siljamäki E, Mahoney M, Putaala H, Suominen E, Peltonen J, et al. Hailey-Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes. Exp Dermatol. 2012;21:586-91 pubmed publisher
  62. Rittner H, Amasheh S, Moshourab R, Hackel D, Yamdeu R, Mousa S, et al. Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia. Anesthesiology. 2012;116:1323-34 pubmed publisher
  63. Ritchie J, Rui H, Zhou X, Iida T, Kodoma T, Ito S, et al. Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog. 2012;8:e1002593 pubmed publisher
  64. Van den Bossche J, Laoui D, Morias Y, Movahedi K, Raes G, De Baetselier P, et al. Claudin-1, claudin-2 and claudin-11 genes differentially associate with distinct types of anti-inflammatory macrophages in vitro and with parasite- and tumour-elicited macrophages in vivo. Scand J Immunol. 2012;75:588-98 pubmed publisher
  65. Chang H, Zhang C, Cao Y. Expression and distribution of symplekin regulates the assembly and function of the epithelial tight junction. Histochem Cell Biol. 2012;137:319-27 pubmed publisher
  66. Kyuno D, Kojima T, Ito T, Yamaguchi H, Tsujiwaki M, Takasawa A, et al. Protein kinase C? inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Cell Tissue Res. 2011;346:369-81 pubmed publisher
  67. Fujita T, Firth J, Kittaka M, Ekuni D, Kurihara H, Putnins E. Loss of claudin-1 in lipopolysaccharide-treated periodontal epithelium. J Periodontal Res. 2012;47:222-7 pubmed publisher
  68. Wu C, Jhingory S, Taneyhill L. The tight junction scaffolding protein cingulin regulates neural crest cell migration. Dev Dyn. 2011;240:2309-23 pubmed publisher
  69. Mandel I, Paperna T, Glass Marmor L, Volkowich A, Badarny S, Schwartz I, et al. Tight junction proteins expression and modulation in immune cells and multiple sclerosis. J Cell Mol Med. 2012;16:765-75 pubmed publisher
  70. Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, et al. Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles. J Virol. 2011;85:7613-21 pubmed publisher
  71. Kirschner N, Haftek M, Niessen C, Behne M, Furuse M, Moll I, et al. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol. 2011;131:932-43 pubmed publisher
  72. Gladden A, Hebert A, Schneeberger E, McClatchey A. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell. 2010;19:727-39 pubmed publisher
  73. Xu H, Wang X, Pahar B, Moroney Rasmussen T, Alvarez X, Lackner A, et al. Increased B7-H1 expression on dendritic cells correlates with programmed death 1 expression on T cells in simian immunodeficiency virus-infected macaques and may contribute to T cell dysfunction and disease progression. J Immunol. 2010;185:7340-8 pubmed publisher
  74. Liu S, Kuo W, Yang W, Liu W, Gibson G, Dorko K, et al. The second extracellular loop dictates Occludin-mediated HCV entry. Virology. 2010;407:160-70 pubmed publisher
  75. Lasagni L, Ballerini L, Angelotti M, Parente E, Sagrinati C, Mazzinghi B, et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28:1674-85 pubmed publisher
  76. Burgel B, Friesland M, Koch A, Manns M, Wedemeyer H, Weissenborn K, et al. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration. J Viral Hepat. 2011;18:562-70 pubmed publisher
  77. Kojima T, Fuchimoto J, Yamaguchi H, Ito T, Takasawa A, Ninomiya T, et al. c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J Cell Physiol. 2010;225:720-33 pubmed publisher
  78. Ciesek S, Steinmann E, Iken M, Ott M, Helfritz F, Wappler I, et al. Glucocorticosteroids increase cell entry by hepatitis C virus. Gastroenterology. 2010;138:1875-84 pubmed publisher
  79. Karim M, Biswas S, Bhattacherjee P, Paterson C. Comparison of tight junction protein expression in the ciliary epithelia of mouse, rabbit, cat and human eyes. Biotech Histochem. 2011;86:161-7 pubmed publisher
  80. Ohkuni T, Kojima T, Ogasawara N, Masaki T, Ninomiya T, Kikuchi S, et al. Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol. 2009;42:204-11 pubmed publisher
  81. Owen D, Huang H, Ye J, Gale M. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology. 2009;394:99-108 pubmed publisher
  82. McLaughlin J, Lambert D, Padfield P, Burt J, O Neill C. The mycotoxin patulin, modulates tight junctions in caco-2 cells. Toxicol In Vitro. 2009;23:83-9 pubmed publisher
  83. Yang W, Hood B, Chadwick S, Liu S, Watkins S, Luo G, et al. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology. 2008;48:1396-403 pubmed publisher
  84. Neuhaus W, Wirth M, Plattner V, Germann B, Gabor F, Noe C. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci Lett. 2008;446:59-64 pubmed publisher
  85. Bouschbacher M, Bomsel M, Verronèse E, Gofflo S, Ganor Y, Dezutter Dambuyant C, et al. Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS. 2008;22:1257-66 pubmed publisher
  86. Yang W, Qiu C, Biswas N, Jin J, Watkins S, Montelaro R, et al. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus. J Biol Chem. 2008;283:8643-53 pubmed publisher
  87. Troy T, Arabzadeh A, Yerlikaya S, Turksen K. Claudin immunolocalization in neonatal mouse epithelial tissues. Cell Tissue Res. 2007;330:381-8 pubmed
  88. Moser L, Carter M, Schultz Cherry S. Astrovirus increases epithelial barrier permeability independently of viral replication. J Virol. 2007;81:11937-45 pubmed
  89. Arabzadeh A, Troy T, Turksen K. Claudin expression modulations reflect an injury response in the murine epidermis. J Invest Dermatol. 2008;128:237-40 pubmed
  90. Go M, Kojima T, Takano K, Murata M, Ichimiya S, Tsubota H, et al. Expression and function of tight junctions in the crypt epithelium of human palatine tonsils. J Histochem Cytochem. 2004;52:1627-38 pubmed
  91. Saathoff M, Blum B, Quast T, Kirfel G, Herzog V. Simultaneous cell death and desquamation of the embryonic diffusion barrier during epidermal development. Exp Cell Res. 2004;299:415-26 pubmed
  92. Morita H, Katsuno T, Hoshimoto A, Hirano N, Saito Y, Suzuki Y. Connexin 26-mediated gap junctional intercellular communication suppresses paracellular permeability of human intestinal epithelial cell monolayers. Exp Cell Res. 2004;298:1-8 pubmed
  93. Palovuori R, Sormunen R, Eskelinen S. SRC-induced disintegration of adherens junctions of madin-darby canine kidney cells is dependent on endocytosis of cadherin and antagonized by Tiam-1. Lab Invest. 2003;83:1901-15 pubmed
  94. Tedelind S, Ericson L, Karlsson J, Nilsson M. Interferon-gamma down-regulates claudin-1 and impairs the epithelial barrier function in primary cultured human thyrocytes. Eur J Endocrinol. 2003;149:215-21 pubmed
  95. Castillo A, Reyes J, Sanchez E, Mondragon R, Meza I. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers. J Muscle Res Cell Motil. 2002;23:223-34 pubmed
  96. Gallardo J, Hernandez J, Contreras R, Flores Maldonado C, Gonzalez Mariscal L, Cereijido M. Tight junctions are sensitive to peptides eliminated in the urine. J Membr Biol. 2002;188:33-42 pubmed
  97. Contreras R, Shoshani L, Flores Maldonado C, Lazaro A, Monroy A, Roldán M, et al. E-Cadherin and tight junctions between epithelial cells of different animal species. Pflugers Arch. 2002;444:467-75 pubmed
  98. Reyes J, Lamas M, Martin D, del Carmen Namorado M, Islas S, Luna J, et al. The renal segmental distribution of claudins changes with development. Kidney Int. 2002;62:476-87 pubmed